Amy Raskopf | VP, IR |
Saundra Pelletier | President, CEO & Director |
Justin File | CFO |
Russell Barrans | Chief Commercial Officer |
Raghuram Selvaraju | H.C. Wainwright & Co. |
Annabel Samimy | Stifel, Nicolaus & Company |
David Amsellem | Piper Sandler & Co. |
Jeff Hung | Morgan Stanley |
Good afternoon, and welcome to Evofem Biosciences Second Quarter 2021 Results Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to turn the call over to Evofem's Vice President of Investor Relations, Amy Raskopf.
Thank you, and good afternoon, everyone.